A meta-analysis indicated decreased omentin concentrations in subjects with T2D and gestational diabetes compared to normoglycemic controls [20], while different studies have reported an increase in its levels in obesity, possibly as a counterregulatory mechanism to protect against insulin resistance [21]. Here, ITLN1 is linked to type 2 diabetes mellitus.